Attached files
| file | filename |
|---|---|
| S-1/A - S-1/A - IRONWOOD PHARMACEUTICALS INC | a2195675zs-1a.htm |
| EX-1.1 - EXHIBIT 1.1 - IRONWOOD PHARMACEUTICALS INC | a2195978zex-1_1.htm |
| EX-10.4 - EXHIBIT 10.4 - IRONWOOD PHARMACEUTICALS INC | a2195978zex-10_4.htm |
| EX-10.5 - EXHIBIT 10.5 - IRONWOOD PHARMACEUTICALS INC | a2195978zex-10_5.htm |
| EX-3.2 - EXHIBIT 3.2 - IRONWOOD PHARMACEUTICALS INC | a2195978zex-3_2.htm |
| EX-4.1 - EXHIBIT 4.1 - IRONWOOD PHARMACEUTICALS INC | a2195978zex-4_1.htm |
| EX-3.4 - EXHIBIT 3.4 - IRONWOOD PHARMACEUTICALS INC | a2195978zex-3_4.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts” and to the use of our report dated November 20, 2009, in Amendment No. 2 to the Registration Statement (Form S-1 File No. 333-163275) and the related Prospectus of Ironwood Pharmaceuticals, Inc. for the registration of shares of its Class A common stock.
|
|
/s/ Ernst & Young LLP |
Boston, Massachusetts
January 19, 2010